Repetitive transcranial magnetic stimulation for patients with functional paralysis: a randomized controlled study.
clinical trials
controlled
functional motor signs
randomized
transcranial magnetic stimulation
Journal
European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
received:
24
12
2021
accepted:
20
01
2022
pubmed:
1
2
2022
medline:
13
4
2022
entrez:
31
1
2022
Statut:
ppublish
Résumé
Repetitive transcranial magnetic stimulation (rTMS) has been proposed to treat functional neurological disorders. Here, the aim was to assess the efficacy of rTMS to treat functional paralysis in a controlled randomized trial. Patients received two sessions of active or sham 0.25 Hz rTMS (60 stimuli each), with a 1-day interval, applied over the motor cortex contralateral to the paralysis. The primary outcome was the number of patients with an increase in motor score between baseline and after the second rTMS session, rated by two investigators blinded to the treatment allocation. Secondary outcomes were changes in global and fine motor scores between groups after rTMS, and the occurrence of adverse events. Sixty-two patients (46 female; mean [SD] age, 35.2 [13.9] years) were enrolled and randomized. Thirteen out of 32 (41%) and 11/30 (37%) patients had increased motor strength after active or sham rTMS, respectively (p = 0.80). Changes in both global and fine motor scores after rTMS relative to baseline were also not significantly different between treatment groups (median difference in the global motor score 0.62 [0.83] and 0.37 [0.61], and in the fine motor scores 0.12 [0.18] and 0.08 [0.11], in active and sham rTMS groups, respectively; p = 0.14). Six serious adverse events, consisting of three cephalalgia in the active group and two cephalalgia and one asthenia in the sham group, were observed. Two sessions of sham or active low frequency rTMS were effective to improve functional paralysis, suggesting a placebo effect of this non-invasive brain stimulation technique.
Sections du résumé
BACKGROUND AND PURPOSE
Repetitive transcranial magnetic stimulation (rTMS) has been proposed to treat functional neurological disorders. Here, the aim was to assess the efficacy of rTMS to treat functional paralysis in a controlled randomized trial.
METHODS
Patients received two sessions of active or sham 0.25 Hz rTMS (60 stimuli each), with a 1-day interval, applied over the motor cortex contralateral to the paralysis. The primary outcome was the number of patients with an increase in motor score between baseline and after the second rTMS session, rated by two investigators blinded to the treatment allocation. Secondary outcomes were changes in global and fine motor scores between groups after rTMS, and the occurrence of adverse events.
RESULTS
Sixty-two patients (46 female; mean [SD] age, 35.2 [13.9] years) were enrolled and randomized. Thirteen out of 32 (41%) and 11/30 (37%) patients had increased motor strength after active or sham rTMS, respectively (p = 0.80). Changes in both global and fine motor scores after rTMS relative to baseline were also not significantly different between treatment groups (median difference in the global motor score 0.62 [0.83] and 0.37 [0.61], and in the fine motor scores 0.12 [0.18] and 0.08 [0.11], in active and sham rTMS groups, respectively; p = 0.14). Six serious adverse events, consisting of three cephalalgia in the active group and two cephalalgia and one asthenia in the sham group, were observed.
CONCLUSIONS
Two sessions of sham or active low frequency rTMS were effective to improve functional paralysis, suggesting a placebo effect of this non-invasive brain stimulation technique.
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1293-1302Informations de copyright
© 2022 European Academy of Neurology.
Références
Stone J, Carson A, Duncan R, et al. Who is referred to neurology clinics?-The diagnoses made in 3781 new patients. Clin Neurol Neurosurg. 2010;112(9):747-751. doi:10.1016/j.clineuro.2010.05.011
Stone J, Carson A, Duncan R, et al. Symptoms “unexplained by organic disease” in 1144 new neurology out-patients: how often does the diagnosis change at follow-up? Brain. 2009;132(10):2878-2888. doi:10.1093/brain/awp220
Carson AJ, Stone J, Hansen CH, et al. Somatic symptom count scores do not identify patients with symptoms unexplained by disease: a prospective cohort study of neurology outpatients. J Neurol Neurosurg Psychiatry. 2015;86(3):295-301. doi:10.1136/jnnp-2014-308234
Stone J, Sharpe M, Rothwell PM, Warlow CP. The 12 year prognosis of unilateral functional weakness and sensory disturbance. J Neurol Neurosurg Psychiatry. 2003;74(5):591-596. doi:10.1136/jnnp.74.5.591
Gelauff JM, Carson A, Ludwig L, Tijssen MAJ, Stone J. The prognosis of functional limb weakness: a 14-year case-control study. Brain. 2019;142(7):2137-2148. doi:10.1093/brain/awz138
Nicholson TR, Carson A, Edwards MJ, et al. Outcome measures for functional neurological disorder: a review of the theoretical complexities. J Neuropsychiatry Clin Neurosci. 2020;32(1):33-42. doi:10.1176/appi.neuropsych.19060128
Gelauff J, Stone J, Edwards M, Carson A. The prognosis of functional (psychogenic) motor symptoms: a systematic review. J Neurol Neurosurg Psychiatry. 2014;85(2):220-226.
Gelauff JM, Kingma EM, Kalkman JS, et al. Fatigue, not self-rated motor symptom severity, affects quality of life in functional motor disorders. J Neurol. 2018;265(8):1803-1809. doi:10.1007/s00415-018-8915-7
Ludwig L, Pasman JA, Nicholson T, et al. Stressful life events and maltreatment in conversion (functional neurological) disorder: systematic review and meta-analysis of case-control studies. Lancet Psychiatry. 2018;5(4):307-320. doi:10.1016/S2215-0366(18)30051-8
Burgmer M, Konrad C, Jansen A, et al. Abnormal brain activation during movement observation in patients with conversion paralysis. NeuroImage. 2006;29(4):1336-1343. doi:10.1016/j.neuroimage.2005.08.033
Stone J, Zeman A, Simonotto E, et al. FMRI in patients with motor conversion symptoms and controls with simulated weakness. Psychosom Med. 2007;69(9):961-969. doi:10.1097/PSY.0b013e31815b6c14
Vuilleumier P, Chicherio C, Assal F, Schwartz S, Slosman D, Landis T. Functional neuroanatomical correlates of hysterical sensorimotor loss. Brain. 2001;124(6):1077-1090. doi:10.1093/brain/124.6.1077
Vuilleumier P. Brain circuits implicated in psychogenic paralysis in conversion disorders and hypnosis. Neurophysiol Clin. 2014;44(4):323-337. doi:10.1016/j.neucli.2014.01.003
Perez DL, Nicholson TR, Asadi-Pooya AA, et al. Neuroimaging in functional neurological disorder: state of the field and research agenda. NeuroImage Clin. 2021;30:102623. doi:10.1016/j.nicl.2021.102623
Bègue I, Adams C, Stone J, Perez DL. Structural alterations in functional neurological disorder and related conditions: a software and hardware problem? NeuroImage Clin. 2019;22:101798. doi:10.1016/j.nicl.2019.101798
de Lange FP, Roelofs K, Toni I. Increased self-monitoring during imagined movements in conversion paralysis. Neuropsychologia. 2007;45(9):2051-2058. doi:10.1016/j.neuropsychologia.2007.02.002
Kranick SM, Moore JW, Yusuf N, et al. Action-effect binding is decreased in motor conversion disorder: implications for sense of agency. Mov Disord. 2013;28(8):1110-1116. doi:10.1002/mds.25408
Nahab FB, Kundu P, Maurer C, Shen Q, Hallett M. Impaired sense of agency in functional movement disorders: an fMRI study. PLoS One. 2017;12(4):e0172502. doi:10.1371/journal.pone.0172502
Espay AJ, Aybek S, Carson A, et al. Current concepts in diagnosis and treatment of functional neurological disorders. JAMA Neurol. 2018;75(9):1132. doi:10.1001/jamaneurol.2018.1264
Nielsen G, Stone J, Matthews A, et al. Physiotherapy for functional motor disorders: a consensus recommendation. J Neurol Neurosurg Psychiatry. 2015;86(10):1113-1119. doi:10.1136/jnnp-2014-309255
Nicholson C, Edwards MJ, Carson AJ, et al. Occupational therapy consensus recommendations for functional neurological disorder. J Neurol Neurosurg Psychiatry. 2020;91(10):1037-1045. doi:10.1136/jnnp-2019-322281
Gelauff JM, Dreissen YEM, Tijssen MAJ, Stone J. Treatment of functional motor disorders. Curr Treat Options Neurol. 2014;16:286. doi:10.1007/s11940-014-0286-5
McWhirter L, Carson A, Stone J. The body electric: a long view of electrical therapy for functional neurological disorders. Brain. 2015;138(4):1113-1120. doi:10.1093/brain/awv009
Moene FC, Spinhoven P, Hoogduin KAL, Van Dyck R. A randomized controlled clinical trial of a hypnosis-based treatment for patients with conversion disorder, motor type. Int J Clin Exp Hypn. 2003;51(1):29-50. doi:10.1076/iceh.51.1.29.14067
Dallocchio C, Arbasino C, Klersy C, Marchioni E. The effects of physical activity on psychogenic movement disorders. Mov Disord. 2010;25(4):421-425. doi:10.1002/mds.22952
Lehn A, Gelauff J, Hoeritzauer I, et al. Functional neurological disorders: mechanisms and treatment. J Neurol. 2016;263(3):611-620. doi:10.1007/s00415-015-7893-2
Pollak TA, Nicholson TR, Edwards MJ, David AS. A systematic review of transcranial magnetic stimulation in the treatment of functional (conversion) neurological symptoms. J Neurol Neurosurg Psychiatry. 2014;85(2):191-197. doi:10.1136/jnnp-2012-304181
Nielsen G, Buszewicz M, Stevenson F, et al. Randomised feasibility study of physiotherapy for patients with functional motor symptoms. J Neurol Neurosurg Psychiatry. 2017;88(6):484-490. doi:10.1136/jnnp-2016-314408
Jordbru AA, Smedstad LM, Klungsoyr O, Martinsen EW. Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up. J Rehabil Med. 2014;46(2):181-187.
Taib S, Ory-Magne F, Brefel-Courbon C, et al. Repetitive transcranial magnetic stimulation for functional tremor: a randomized, double-blind, controlled study. Mov Disord. 2019;34(8):1210-1219. doi:10.1002/mds.27727
Garcin B, Roze E, Mesrati F, et al. Transcranial magnetic stimulation as an efficient treatment for psychogenic movement disorders. J Neurol Neurosurg Psychiatry. 2013;84(9):1043-1046. doi:10.1136/jnnp-2012-304062
Garcin B, Mesrati F, Hubsch C, et al. Impact of transcranial magnetic stimulation on functional movement disorders: cortical modulation or a behavioral effect? Front Neurol. 2017;8:338. doi:10.3389/fneur.2017.00338
Pick S, Hodsoll J, Stanton B, et al. Trial of Neurostimulation in Conversion Symptoms (TONICS): a feasibility randomised controlled trial of transcranial magnetic stimulation for functional limb weakness. BMJ Open. 2020;10(10):e037198. doi:10.1136/bmjopen-2020-037198
McWhirter L, Ludwig L, Carson A, McIntosh RD, Stone J. Transcranial magnetic stimulation as a treatment for functional (psychogenic) upper limb weakness. J Psychosom Res. 2016;89:102-106. doi:10.1016/j.jpsychores.2016.08.010
Chastan N, Parain D. Psychogenic paralysis and recovery after motor cortex transcranial magnetic stimulation. Mov Disord. 2010;25(10):1501-1504. doi:10.1002/mds.23187
APA. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). American Psychiatric Publishing, Inc.; 2000.
Lefaucheur JP, Andre-Obadia N, Poulet E, et al. French guidelines on the use of repetitive transcranial magnetic stimulation (rTMS): safety and therapeutic indications. Neurophysiol Clin. 2011;41(5-6):221-295.
Chastan N, Parain D, Vérin E, Weber J, Faure MA, Marie JP. LETTERS psychogenic aphonia: spectacular recovery after motor cortex transcranial magnetic stimulation. J Neurol Neurosurg Psychiatry. 2009;80(1):94. doi:10.1136/jnnp.2008.154302
Preisig M, Fenton BT, Matthey M-L, Berney A, Ferrero F. Diagnostic interview for genetic studies (DIGS): inter-rater and test-retest reliability of the French version. Eur Arch Psychiatry Clin Neurosci. 1999;249(4):174-179.
Kaufman J, Birmaher B, Brent D, et al. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36(7):980-988. doi:10.1097/00004583-199707000-00021
Efron B. Better bootstrap confidence intervals. J Am Stat Assoc. 1987;82(397):171. doi:10.2307/2289144
Broersma M, Koops EA, Vroomen PC, et al. Can repetitive transcranial magnetic stimulation increase muscle strength in functional neurological paresis? A proof-of-principle study. Eur J Neurol. 2015;22(5):866-873. doi:10.1111/ene.12684
Chen R, Classen J, Gerloff C, et al. Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology. 1997;48(5):1398-1403.
Touge T, Gerschlager W, Brown P, Rothwell JC. Are the after-effects of low-frequency rTMS on motor cortex excitability due to changes in the efficacy of cortical synapses? Clin Neurophysiol. 2001;112(11):2138-2145. doi:10.1016/S1388-2457(01)00651-4
Dreissen YEM, Dijk JM, Gelauff JM, et al. Botulinum neurotoxin treatment in jerky and tremulous functional movement disorders: a double-blind, randomised placebo-controlled trial with an open-label extension. J Neurol Neurosurg Psychiatry. 2019;90(11):1244-1250. doi:10.1136/jnnp-2018-320071
Baizabal-Carvallo JF, Hallett M, Jankovic J. Pathogenesis and pathophysiology of functional (psychogenic) movement disorders. Neurobiol Dis. 2019;127:32-44. doi:10.1016/j.nbd.2019.02.013
Edwards MJ, Adams RA, Brown H, Pareés I, Friston KJ. A Bayesian account of “hysteria”. Brain. 2012;135(11):3495-3512. doi:10.1093/brain/aws129
Jonas WB, Crawford C, Colloca L, et al. To what extent are surgery and invasive procedures effective beyond a placebo response? A systematic review with meta-analysis of randomised, sham controlled trials. BMJ Open. 2015;5(12):e009655. doi:10.1136/bmjopen-2015-009655
Colloca L, Barsky AJ. Placebo and nocebo effects. N Engl J Med. 2020;382(6):554-561. doi:10.1056/nejmra1907805
Pick S, Anderson DG, Asadi-Pooya AA, et al. Outcome measurement in functional neurological disorder: a systematic review and recommendations. J Neurol Neurosurg Psychiatry. 2020;91(6):638-649. doi:10.1136/jnnp-2019-322180
Espay AJ, Lang AE. Phenotype-specific diagnosis of functional (psychogenic) movement disorders. Curr Neurol Neurosci Rep. 2015;15:32. doi:10.1007/s11910-015-0556-y
Faul L, Knight LK, Espay AJ, Depue BE, LaFaver K. Neural activity in functional movement disorders after inpatient rehabilitation. Psychiatry Res Neuroimaging. 2020;303:111125. doi:10.1016/j.pscychresns.2020.111125